600196.SS vs BAJAJFINSV.NS — which is stronger right now?
Same dated snapshot (2026-09-01): 600196.SS quality —/100 vs BAJAJFINSV.NS —/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 600196.SS (Fosun Pharma) | BAJAJFINSV.NS (Bajaj Finserv) | |
| Market / sector | ashare · Pharma | in · Financials |
| Price | ¥22.84 | ₹2,004 |
| Quality score | —/100 | —/100 |
| Engine signal | LONG · 38 bars · uPnL -3.6% | LONG · 39 bars · uPnL +8.0% |
| Total return | -1.8% | -17.7% |
Thesis-break template (Pharma)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "600196.SS vs BAJAJFINSV.NS — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/600196.ss-vs-bajajfinsv.ns · CC BY 4.0
Ask anything
Ask AI: 600196.SS vs BAJAJFINSV.NS?What breaks the 600196.SS thesis?What breaks the BAJAJFINSV.NS thesis?
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice